AMD3100/Plerixafor overcomes immune inhibition by the CXCL12-KRT19 coating on pancreatic and colorectal cancer cells

被引:18
作者
Fearon, Douglas T. [1 ,2 ]
Janowitz, Tobias [1 ,3 ]
机构
[1] Cold Spring Harbor Lab, POB 100, Cold Spring Harbor, NY 11724 USA
[2] Weill Cornell Med, New York, NY 10021 USA
[3] Northwell Hlth, Canc Inst, New Hyde Pk, NY USA
关键词
IMMUNOTHERAPY;
D O I
10.1038/s41416-021-01315-y
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
A recent Phase 1 clinical study of the immunological effects of inhibiting the chemokine receptor, CXCR4, in patients with pancreatic ductal adenocarcinoma or colorectal cancer suggests that stimulation of CXCR4 on immune cells suppresses the intratumoural immune reaction. Here, we discuss how CXCR4 mediates this response, and how cancer cells elicit it.
引用
收藏
页码:149 / 151
页数:3
相关论文
共 10 条
[1]   CXCR4 inhibition in human pancreatic and colorectal cancers induces an integrated immune response [J].
Biasci, Daniele ;
Smoragiewicz, Martin ;
Connell, Claire M. ;
Wang, Zhikai ;
Gao, Ya ;
Thaventhiran, James E. D. ;
Basu, Bristi ;
Magiera, Lukasz ;
Johnson, T. Isaac ;
Bax, Lisa ;
Gopinathan, Aarthi ;
Isherwood, Christopher ;
Gallagher, Ferdia A. ;
Pawula, Maria ;
Hudecova, Irena ;
Gale, Davina ;
Rosenfeld, Nitzan ;
Barmpounakis, Petros ;
Popa, Elizabeta Cristina ;
Brais, Rebecca ;
Godfrey, Edmund ;
Mir, Fraz ;
Richards, Frances M. ;
Fearo, Douglas T. ;
Janowitz, Tobias ;
Jodrell, Duncan I. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2020, 117 (46) :28960-28970
[2]   Intratumoral Activity of the CXCR3 Chemokine System Is Required for the Efficacy of Anti-PD-1 Therapy [J].
Chow, Melvyn T. ;
Ozga, Aleksandra J. ;
Servis, Rachel L. ;
Frederick, Dennie T. ;
Lo, Jennifer A. ;
Fisher, David E. ;
Freeman, Gordon J. ;
Boland, Genevieve M. ;
Luster, Andrew D. .
IMMUNITY, 2019, 50 (06) :1498-+
[3]   Targeting CXCL12 from FAP-expressing carcinomaassociated fibroblasts synergizes with anti-PD-L1 immunotherapy in pancreatic cancer [J].
Feig, Christine ;
Jones, James O. ;
Kraman, Matthew ;
Wells, Richard J. B. ;
Deonarine, Andrew ;
Chan, Derek S. ;
Connell, Claire M. ;
Roberts, Edward W. ;
Zhao, Qi ;
Caballero, Otavia L. ;
Teichmann, Sarah A. ;
Janowitz, Tobias ;
Jodrell, Duncan I. ;
Tuveson, David A. ;
Fearon, Douglas T. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2013, 110 (50) :20212-20217
[4]   NOX4 Inhibition Potentiates Immunotherapy by Overcoming Cancer-Associated Fibroblast-Mediated CD8 T-cell Exclusion from Tumors [J].
Ford, Kirsty ;
Hanley, Christopher J. ;
Mellone, Massimiliano ;
Szyndralewiez, Cedric ;
Heitz, Freddy ;
Wiesel, Philippe ;
Wood, Oliver ;
Machado, Maria ;
Lopez, Maria-Antoinette ;
Ganesan, Anusha-Preethi ;
Wang, Chuan ;
Chakravarthy, Ankur ;
Fenton, Tim R. ;
King, Emma V. ;
Vijayanand, Pandurangan ;
Ottensmeier, Christian H. ;
Al-Shamkhani, Aymen ;
Savelyeva, Natalia ;
Thomas, Gareth J. .
CANCER RESEARCH, 2020, 80 (09) :1846-1860
[5]   T cell exclusion, immune privilege, and the tumor microenvironment [J].
Joyce, Johanna A. ;
Fearon, Douglas T. .
SCIENCE, 2015, 348 (6230) :74-80
[6]   Stromal SOX2 Upregulation Promotes Tumorigenesis through the Generation of a SFRP1/2-Expressing Cancer-Associated Fibroblast Population [J].
Kasashima, Hiroaki ;
Duran, Angeles ;
Martinez-Ordonez, Anxo ;
Nakanishi, Yuki ;
Kinoshita, Hiroto ;
Linares, Juan F. ;
Reina-Campos, Miguel ;
Kudo, Yotaro ;
L'Hermitte, Antoine ;
Yashiro, Masakazu ;
Ohira, Masaichi ;
Bao, Fei ;
Tauriello, Daniele V. F. ;
Batlle, Eduard ;
Diaz-Meco, Maria T. ;
Moscat, Jorge .
DEVELOPMENTAL CELL, 2021, 56 (01) :95-+
[7]   Immunotherapy Converts Nonimmunogenic Pancreatic Tumors into Immunogenic Foci of Immune Regulation [J].
Lutz, Eric R. ;
Wu, Annie A. ;
Bigelow, Elaine ;
Sharma, Rajni ;
Mo, Guanglan ;
Soares, Kevin ;
Solt, Sara ;
Dorman, Alvin ;
Wamwea, Anthony ;
Yager, Allison ;
Laheru, Daniel ;
Wolfgang, Christopher L. ;
Wang, Jiang ;
Hruban, Ralph H. ;
Anders, Robert A. ;
Jaffee, Elizabeth M. ;
Zheng, Lei .
CANCER IMMUNOLOGY RESEARCH, 2014, 2 (07) :616-631
[8]   CD8 T Cell Exhaustion During Chronic Viral Infection and Cancer [J].
McLane, Laura M. ;
Abdel-Hakeem, Mohamed S. ;
Wherry, E. John .
ANNUAL REVIEW OF IMMUNOLOGY, VOL 37, 2019, 2019, 37 :457-495
[9]   TOX is a critical regulator of tumour-specific T cell differentiation [J].
Scott, Andrew C. ;
Dundar, Friederike ;
Zumbo, Paul ;
Chandran, Smita S. ;
Klebanoff, Christopher A. ;
Shakiba, Mojdeh ;
Trivedi, Prerak ;
Menocal, Laura ;
Appleby, Heather ;
Camara, Steven ;
Zamarin, Dmitriy ;
Walther, Tyler ;
Snyder, Alexandra ;
Femia, Matthew R. ;
Comen, Elizabeth A. ;
Wen, Hannah Y. ;
Hellmann, Matthew D. ;
Anandasabapathy, Niroshana ;
Liu, Yong ;
Altorki, Nasser K. ;
Lauer, Peter ;
Levy, Olivier ;
Glickman, Michael S. ;
Kaye, Jonathan ;
Betel, Doron ;
Philip, Mary ;
Schietinger, Andrea .
NATURE, 2019, 571 (7764) :270-+
[10]  
Wang Z., 2020, PREPRINT BIORXIV, DOI 10.1101/776419